Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding

Atypical hemolytic uremic syndrome (aHUS) is an extremely rare condition caused by an excessive activation of the complement pathway based on genetic or acquired dysfunctions in complement regulation, leading to thrombotic microangiopathy (TMA). A complement-amplifying condition (CAC) can trigger aH...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Yoko, Terashita, Maho, Yazawa, Masahiko, Yamasaki, Yukitaka, Imamura, Tomonori, Kibayashi, Junichiro, Sawai, Toshihiro, Hidaka, Yoshihiko, Ohtani, Katsuki, Inoue, Norimitsu, Shibagaki, Yugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995713/
https://www.ncbi.nlm.nih.gov/pubmed/31902910
http://dx.doi.org/10.2169/internalmedicine.3315-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995713/
https://www.ncbi.nlm.nih.gov/pubmed/31902910
http://dx.doi.org/10.2169/internalmedicine.3315-19

Ejemplares similares